These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20424472)

  • 1. Characteristics, cardiovascular comorbidity and medicines management in patients with type 2 diabetes and CKD: results of the IRIDIEM study.
    Stevens PE; Schernthaner G; Raptis S; Wanner C; Scherhag A; Lameire N
    Kidney Blood Press Res; 2010; 33(2):119-28. PubMed ID: 20424472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects.
    Bailie GR; Eisele G; Liu L; Roys E; Kiser M; Finkelstein F; Wolfe R; Port F; Burrows-Hudson S; Saran R
    Nephrol Dial Transplant; 2005 Jun; 20(6):1110-5. PubMed ID: 15769809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TREAT or not to treat: anemia in type 2 diabetes and chronic kidney disease at stages 3 and 4].
    Choukroun G; Renou M; Lecaque C; Jauréguy M
    Nephrol Ther; 2011 Feb; 7(1):2-9. PubMed ID: 21216683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC; Tsai WC; Chen JY; Huang JJ
    Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of renal and cardiovascular risk factors in Toba Aborigines.
    Bianchi ME; Farías EF; Bolaño J; Massari PU
    Ren Fail; 2006; 28(8):665-70. PubMed ID: 17162424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Whaley-Connell AT; Sowers JR; Stevens LA; McFarlane SI; Shlipak MG; Norris KC; Chen SC; Qiu Y; Wang C; Li S; Vassalotti JA; Collins AJ;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S13-20. PubMed ID: 18359403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].
    Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):753-9. PubMed ID: 15949381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
    Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
    Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk levels in general practice patients with type 2 diabetes in rural and urban areas.
    Wan Q; Harris MF; Powell-Davies G; Jayasinghe UW; Flack J; Georgiou A; Burns JR; Penn DL
    Aust J Rural Health; 2007 Oct; 15(5):327-33. PubMed ID: 17760917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study.
    Thilly N; Boini S; Kessler M; Briançon S; Frimat L
    J Eval Clin Pract; 2009 Feb; 15(1):121-8. PubMed ID: 19239592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of type 2 diabetes mellitus: is it in accordance with the guidelines?
    Chan GC; Ghazali O; Khoo EM
    Med J Malaysia; 2005 Dec; 60(5):578-84. PubMed ID: 16515108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
    Collins AJ; Vassalotti JA; Wang C; Li S; Gilbertson DT; Liu J; Foley RN; Chen SC; Arneson TJ
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S71-7. PubMed ID: 19231764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.